The federal government has announced deals to buy millions of potential COVID-19 vaccine doses from two American drug companies, on top of its existing deal with two other U.S. firms. The government is aggressively looking for backup plans after its deal with a Chinese company CanSino fell apart recently.

More in HEALTH